Greylin Investment Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $430K | Sell |
|
|||||
|
2024
Q1 | $327K | Sell |
|
|||||
|
2023
Q4 | $319K | Sell |
|
|||||
|
2023
Q3 | $356K | Hold |
|
|||||
|
2023
Q2 | $348K | Sell |
|
|||||
|
2023
Q1 | $442K | Sell |
|
|||||
|
2022
Q4 | $633K | Sell |
|
|||||
|
2022
Q3 | $492K | Sell |
|
|||||
|
2022
Q2 | $566K | Sell |
|
|||||
|
2022
Q1 | $457K | Sell |
|
|||||
|
2021
Q4 | $2.04M | Sell |
|
|||||
|
2021
Q3 | $1.76M | Sell |
|
|||||
|
2021
Q2 | $2.55M | Sell |
|
|||||
|
2021
Q1 | $5.39M | Sell |
|
|||||
|
2020
Q4 | $5.44M | Sell |
|
|||||
|
2020
Q3 | $5.37M | Sell |
|
|||||
|
2020
Q2 | $13.9M | Sell |
|
|||||
|
2020
Q1 | $12.7M | Sell |
|
|||||
|
2019
Q4 | $13.8M | Sell |
|
|||||
|
2019
Q3 | $14.2M | Buy |
|
|||||
|
2019
Q2 | $10.8M | Buy |
|
|||||
|
2019
Q1 | $13.8M | Sell |
|
|||||
|
2018
Q4 | $13.2M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $13.4M | Buy |
|
|||||
|
2018
Q1 | $4.35M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $396K | Buy |
|
|||||
|
2017
Q2 | $386K | Buy |
|
|||||
|
2017
Q1 | $283K | Buy |
|